Table 3.
Multivariable Analysis of Diagnosis of HCC Within Overall Cohort | |||
Odds Ratio | 95% CI | P value | |
Age (year) | 1.01 | (0.97–1.04) | 0.51 |
Sex (male) | 1.56 | (0.82–2.99) | 0.17 |
Baseline MELD | 0.98 | (0.91–1.06) | 0.74 |
Baseline Low Platelets (<100 K/μL) | 2.75 | (1.37–5.53) | 0.004 |
Baseline Alpha Fetoprotein | 1.00 | (0.99–1.02) | 0.37 |
Baseline Albumin (<3.4 g/dL) | 2.77 | (1.43–5.35) | 0.002 |
Multivariable Analysis of Diagnosis of HCC Among Patients with Abnormal Imaging | |||
Odds Ratio | 95% CI | P value | |
Age (year) | 1.00 | (0.96–1.04) | 0.83 |
Sex | 1.02 | (0.43–2.41) | 0.06 |
Baseline MELD | 0.92 | (0.81–1.05) | 0.23 |
Baseline Thrombocytopenia (<100 K/μL) | 3.67 | (1.46–9.23) | 0.006 |
Baseline Alpha Fetoprotein | 1.02 | (0.99–1.05) | 0.15 |
Baseline Hypoalbuminemia (<3.4 g/dL) | 4.07 | (1.56–10.63) | 0.004 |
Maximum Nodule Size ≥ 2.0 cm | 8.63 | (3.55–20.92) | <0.001 |
MELD – model of endstage liver disease